- Home
- SRL vs RPTX Comparison
SRL vs RPTX Comparison
Compare SRL & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- RPTX
- Stock Information
- Founded
- SRL 2017
- RPTX 2016
- Country
- SRL China
- RPTX Canada
- Employees
- SRL N/A
- RPTX N/A
- Industry
- SRL Professional Services
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- SRL Consumer Discretionary
- RPTX Health Care
- Exchange
- SRL Nasdaq
- RPTX Nasdaq
- Market Cap
- SRL 81.5M
- RPTX 72.6M
- IPO Year
- SRL N/A
- RPTX 2020
- Fundamental
- Price
- SRL N/A
- RPTX $1.82
- Analyst Decision
- SRL
- RPTX Strong Buy
- Analyst Count
- SRL 0
- RPTX 3
- Target Price
- SRL N/A
- RPTX $4.50
- AVG Volume (30 Days)
- SRL 8.4K
- RPTX 98.0K
- Earning Date
- SRL 04-30-2025
- RPTX 11-06-2025
- Dividend Yield
- SRL 18.91%
- RPTX N/A
- EPS Growth
- SRL N/A
- RPTX N/A
- EPS
- SRL N/A
- RPTX N/A
- Revenue
- SRL $24,535,042.00
- RPTX $250,000.00
- Revenue This Year
- SRL N/A
- RPTX N/A
- Revenue Next Year
- SRL N/A
- RPTX N/A
- P/E Ratio
- SRL N/A
- RPTX N/A
- Revenue Growth
- SRL N/A
- RPTX N/A
- 52 Week Low
- SRL $5.13
- RPTX $0.89
- 52 Week High
- SRL $9.99
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- SRL 46.42
- RPTX 60.62
- Support Level
- SRL $5.48
- RPTX $1.67
- Resistance Level
- SRL $6.00
- RPTX $1.85
- Average True Range (ATR)
- SRL 0.44
- RPTX 0.06
- MACD
- SRL -0.02
- RPTX 0.00
- Stochastic Oscillator
- SRL 10.67
- RPTX 78.38
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.